Champions Oncology, Inc. Share Price & Technical Analysis
CSBR · $6.01 (0.00%)
Healthcare / Biotechnology
$6.01
0.00%
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform t…
Price chart
Seasonality
May has 1 positive and 3 negative years (last 5 years shown)
0% return in May, -6% avg return in past 3 year May month.
-7% return in 2026, 41% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 7% | -17% | -3% | 5% | 0% | – | – | – | – | – | – | – | -7% |
| 25 | 29% | -5% | -16% | -20% | -18% | 25% | -14% | 8% | -3% | 5% | -3% | 5% | -7% |
| 24 | 7% | 2% | -14% | -2% | -8% | 13% | -2% | -14% | 17% | -19% | 18% | 95% | 93% |
| 23 | -11% | 12% | -15% | 20% | 8% | 28% | 3% | 3% | -6% | -8% | -2% | 6% | 38% |
| 22 | -2% | 1% | -1% | -6% | -4% | 8% | 10% | -9% | -4% | -10% | -1% | -36% | -55% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotechnology companies. In addition, the company offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. It markets its products through internet and sales force to pharmaceutical and biotechnology companies. The company was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. Champions Oncology, Inc. was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$83.60M
P/E ratio
—
52W high
$9.63
52W low
$5.50
Volume
412
Beta
0.43
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Champions Oncology, Inc. share price today?
- Champions Oncology, Inc. (CSBR) last traded around $6.01 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CSBR have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CSBR. Download the app for real-time alerts.
- How can I analyze Champions Oncology, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.